242 related articles for article (PubMed ID: 27154394)
1. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.
Taniuchi M; Platts-Mills JA; Begum S; Uddin MJ; Sobuz SU; Liu J; Kirkpatrick BD; Colgate ER; Carmolli MP; Dickson DM; Nayak U; Haque R; Petri WA; Houpt ER
Vaccine; 2016 Jun; 34(27):3068-3075. PubMed ID: 27154394
[TBL] [Abstract][Full Text] [Related]
2. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
[TBL] [Abstract][Full Text] [Related]
3. Enteropathogens and Rotavirus Vaccine Immunogenicity in a Cluster Randomized Trial of Improved Water, Sanitation and Hygiene in Rural Zimbabwe.
Church JA; Rogawski McQuade ET; Mutasa K; Taniuchi M; Rukobo S; Govha M; Lee B; Carmolli MP; Chasekwa B; Ntozini R; McNeal MM; Moulton LH; Kirkpatrick BD; Liu J; Houpt ER; Humphrey JH; Platts-Mills JA; Prendergast AJ
Pediatr Infect Dis J; 2019 Dec; 38(12):1242-1248. PubMed ID: 31738342
[TBL] [Abstract][Full Text] [Related]
4. Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants.
Upfill-Brown A; Taniuchi M; Platts-Mills JA; Kirkpatrick B; Burgess SL; Oberste MS; Weldon W; Houpt E; Haque R; Zaman K; Petri WA
Clin Infect Dis; 2017 Aug; 65(3):414-419. PubMed ID: 28444240
[TBL] [Abstract][Full Text] [Related]
5. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
Emperador DM; Velasquez DE; Estivariz CF; Lopman B; Jiang B; Parashar U; Anand A; Zaman K
Clin Infect Dis; 2016 Jan; 62(2):150-6. PubMed ID: 26349548
[TBL] [Abstract][Full Text] [Related]
6. Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.
Lee B; Carmolli M; Dickson DM; Colgate ER; Diehl SA; Uddin MI; Islam S; Hossain M; Rafique TA; Bhuiyan TR; Alam M; Nayak U; Mychaleckyj JC; McNeal MM; Petri WA; Qadri F; Haque R; Kirkpatrick BD
Clin Infect Dis; 2018 Jul; 67(2):186-192. PubMed ID: 29394355
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB).
Cowley D; Sari RM; Handley A; Watts E; Bachtiar NS; At Thobari J; Satria CD; Bogdanovic-Sakran N; Nirwati H; Orsini F; Lee KJ; Kirkwood CD; Soenarto Y; Bines JE
Vaccine; 2019 Nov; 37(49):7233-7239. PubMed ID: 31607604
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
[TBL] [Abstract][Full Text] [Related]
9. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea.
Haque R; Snider C; Liu Y; Ma JZ; Liu L; Nayak U; Mychaleckyj JC; Korpe P; Mondal D; Kabir M; Alam M; Pallansch M; Oberste MS; Weldon W; Kirkpatrick BD; Petri WA
Vaccine; 2014 Jan; 32(4):478-82. PubMed ID: 24300591
[TBL] [Abstract][Full Text] [Related]
10. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
[TBL] [Abstract][Full Text] [Related]
11. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
[TBL] [Abstract][Full Text] [Related]
12. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age.
Zaman K; Sack DA; Yunus M; Arifeen SE; Podder G; Azim T; Luby S; Breiman RF; Neuzil K; Datta SK; Delem A; Suryakiran PV; Bock HL;
Vaccine; 2009 Feb; 27(9):1333-9. PubMed ID: 19162114
[TBL] [Abstract][Full Text] [Related]
13. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.
Migasena S; Simasathien S; Samakoses R; Pitisuttitham P; Sangaroon P; van Steenis G; Beuvery EC; Bugg H; Bishop R; Davidson BL
Vaccine; 1995 Feb; 13(2):168-74. PubMed ID: 7625111
[TBL] [Abstract][Full Text] [Related]
15. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
[TBL] [Abstract][Full Text] [Related]
16. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
[TBL] [Abstract][Full Text] [Related]
17. Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group.
Markwick AJ; Rennels MB; Zito ET; Wade MS; Mack ME
Pediatr Infect Dis J; 1998 Oct; 17(10):913-8. PubMed ID: 9802635
[TBL] [Abstract][Full Text] [Related]
18. Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
Desai S; Rathi N; Kawade A; Venkatramanan P; Kundu R; Lalwani SK; Dubey AP; Venkateswara Rao J; Narayanappa D; Ghildiyal R; Gogtay NJ; Venugopal P; Palkar S; Munshi R; Bavdekar A; Juvekar S; Ganguly N; Niyogi P; Uttam KG; Kondekar A; Kumbhar D; Mohanlal S; Agarwal MC; Shetty P; Antony K; Gunale B; Dharmadhikari A; Deshpande J; Nalavade U; Sharma D; Bansal A; Tang Y; Flores J; Kulkarni PS
Vaccine; 2018 Sep; 36(37):5519-5523. PubMed ID: 30104114
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
Jalil F; Zaman S; Carlsson B; Glass RI; Kapikian AZ; Mellander L; Hanson LA
Trans R Soc Trop Med Hyg; 1991; 85(2):292-6. PubMed ID: 1653474
[TBL] [Abstract][Full Text] [Related]
20. Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis.
Parker EP; Kampmann B; Kang G; Grassly NC
J Infect Dis; 2014 Sep; 210(6):853-64. PubMed ID: 24688069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
